No two cancers are the same. Let's treat it that way.
Eigen Therapeutics is a biotechnology company developing co-therapies that improve the efficacy of targeted cancer treatments by modulating tumor cell-surface targets. Its AI-driven discovery platform combines high-throughput biology, laboratory robotics, and machine learning to identify combination therapies for cancers with heterogeneous target expression. The approach expands patient eligibility for existing targeted therapies while reducing side effects.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2022
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
